Methyl 2-(4-bromophenyl)acetate → HCID 136132169, Verbindung
Reaktionsgleichung
[NH2:1][C:2]1[N:6]([CH:7]([CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16])[CH2:8][CH2:9][CH3:10])[N:5]=[C:4]([CH2:17][CH2:18][CH3:19])[C:3]=1[C:20]([NH2:22])=[O:21].[Br:23][C:24]1[CH:29]=[CH:28][C:27]([CH2:30][C:31](OC)=O)=[CH:26][CH:25]=1.[O-]CC.[Na+].C(=O)([O-])O.[Na+]>ClCCl>[Br:23][C:24]1[CH:29]=[CH:28][C:27]([CH2:30][C:31]2[NH:22][C:20](=[O:21])[C:3]3[C:4]([CH2:17][CH2:18][CH3:19])=[N:5][N:6]([CH:7]([CH2:11][CH2:12][CH2:13][CH2:14][CH2:15][CH3:16])[CH2:8][CH2:9][CH3:10])[C:2]=3[N:1]=2)=[CH:26][CH:25]=1Komponenten
6
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
10 mg (0.032 mmol) of 5-amino-3-propyl-1-(4-decyl)-1H-pyrazole-4-carboxamide and 20 mg (0.087 mmol) of methyl 4-bromophenylacetate are refluxed for 6 hours in 0.3 ml of a 0.5M ethanolic sodium ethoxide solution. After dichloromethane and saturated aqueous sodium hydrogen carbonate solution have been added, the phases are separated. Purification by chromatography gives 5 mg (53%) of a solid, Rf=0.69 (dichloromethane/methanol=15:1).
Aufarbeitung
- customthe phases are separated
- customPurification by chromatography
Quellen und Nachweise
- ORD-Eintrag
- ord-a122ed5ce60743e0a59095061af4de3b
- Quelldatensatz
- uspto-grants-2001_01
- Patentnummer
- US06174884B1
Notizen zur Reaktion
Wird geladen…